Navigating a ‘Revolutionary Era’ of Targeted Therapy in Pancreatic Cancer

Gregory L. Beatty, MD, PhD, director of Translational Research at the Penn Pancreatic Cancer Research Center, discussed progress in targeted therapy and immunotherapy research for pancreatic cancer.